Prognostic Value of Genomic Analysis after Neoadjuvant Chemotherapy for Breast Cancer

被引：0
|
作者：
Mayer, E. L.
Shak, S.
Miller, K.
Rugo, H.
Carey, L.
Ryabin, N.
Pomeroy, C.
Yoshizawa, C.
Winer, E. P.
Burstein, H. J.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Genom Hlth Inc, Redwood City, CA USA
[3] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[4] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P3-10-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-10-13
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic value of the ratio of positive axillary lymph node after neoadjuvant chemotherapy in Peruvian patients with breast cancer
    Vidaurre, T.
    Calderon, M.
    Mantilla, R.
    Vigil, C. E.
    Leon, M.
    Mas, L.
    Montanez, M.
    Neciosup, S. P.
    Gomez, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy
    Peintinger, Florentia
    Sinn, Bruno
    Hatzis, Christos
    Albarracin, Constance
    Downs-Kelly, Erinn
    Morkowski, Jerzy
    Gould, Rebekah
    Symmans, W. Fraser
    [J]. MODERN PATHOLOGY, 2015, 28 (07) : 913 - 920
  • [23] Prognostic Value of Pathologic Chemotherapy Response Score in Patients With Ovarian Cancer After Neoadjuvant Chemotherapy
    Michaan, Nadav
    Chong, Woo Yoo
    Han, Na Young
    Lim, Myong Cheol
    Park, Sang Yoon
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (09) : 1676 - 1682
  • [24] Prognostic factors after neoadjuvant chemotherapy in breast cancer: Surgery type as a new prognostic factor
    Fujihara, M.
    Kin, T.
    Yoshimura, Y.
    Kajiwara, Y.
    Ito, M.
    Ohtani, S.
    [J]. CANCER RESEARCH, 2017, 77
  • [25] Prognostic factors after neoadjuvant chemotherapy in breast cancer: Surgery type as a new prognostic factor
    Fujihara, M.
    Kin, T.
    Yoshimura, Y.
    Kajiwara, Y.
    Ito, M.
    Abe, K.
    Sakata, Y.
    Hiraki, K.
    Ohtani, S.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [26] Prognostic value of five different histologic scoring systems for tumor regression after neoadjuvant chemotherapy of breast cancer in luminal type breast cancer
    Sinn, P.
    Elsawaf, Z.
    Kaip, G.
    Hell, J.
    Aulmann, S.
    Marme, F.
    Schneeweiss, A.
    [J]. CANCER RESEARCH, 2013, 73
  • [27] Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study
    Gottipati, S.
    Earl, H. M.
    Yau, C.
    Cameron, D. A.
    Abraham, J.
    Hayward, L.
    Reyal, F.
    Osdoit, M.
    Sonke, G. S.
    Wesseling, J.
    Boughey, J.
    Goetz, M. P.
    DeMichele, A.
    Pusztai, L.
    Sharma, P.
    Martin Jimenez, M.
    Lopez-Tarruella Cobo, S.
    Del Monte-Millan, M.
    Symmans, F.
    Mukhtar, R.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S325 - S326
  • [28] Node Micrometastases Detection After Neoadjuvant Chemotherapy in Breast Cancer: Is It of Clinical Value?
    Ziogas, Dimosthenis
    Harissis, Haralampos
    Batsis, Charalabos
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (03) : 933 - 934
  • [29] Node Micrometastases Detection After Neoadjuvant Chemotherapy in Breast Cancer: Is It of Clinical Value?
    Dimosthenis Ziogas
    Haralampos Harissis
    Charalabos Batsis
    [J]. Annals of Surgical Oncology, 2010, 17 : 933 - 934
  • [30] Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy
    Tan, Qi-Xing
    Qin, Qing-Hong
    Yang, Wei-Ping
    Mo, Qin-Guo
    Wei, Chang-Yuan
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 6862 - 6870
12345